Gut hormone leads to weight loss in overweight or obese patients
January 10, 2012 in Overweight and Obesity
Giving overweight or obese patients a gut hormone that suppresses appetite leads to clinically beneficial weight loss as well as reduced blood pressure and cholesterol levels, finds a study published in the British Medical Journal today.
Glucagon-like peptide-1 (GLP-1) is a hormone that is secreted from the intestine when we eat. GLP-1 based therapy was recently introduced as a new treatment for patients with type 2 diabetes because of its ability to regulate blood sugar levels.
But it also suppresses food intake and appetite, making it an interesting approach in the treatment of obesity.
So researchers at the University of Copenhagen set out to determine the effect of glucagon-like peptide-1 receptor (GLP-1R) agonists on weight loss. They also looked at their effect on blood pressure, cholesterol and liver enzyme levels, and blood sugar (glycaemic) control.
They analysed the results of 25 randomised controlled trials involving over 6,000 patients. Differences in study design and quality were taken into account to minimise bias.
They found that patients who received clinically relevant doses of GLP-1R agonists for at least 20 weeks achieved a greater weight loss compared with the control groups.
The benefit was seen for patients with and without type 2 diabetes, but may be more pronounced in patients without diabetes.
GLP-1R agonists also had beneficial effects on blood pressure, cholesterol and improved glycaemic control in patients with type 2 diabetes. There was no statistically significant effect on liver enzymes.
Common side effects included nausea, vomiting and diarrhoea, but did not seem to affect the number of patients dropping out of the trials, suggesting that overall patient satisfaction with the treatment is relatively high.
The authors say that their analysis "provides convincing evidence that GLP-1R agonists, when given to obese patients with or without diabetes, result in clinically relevant beneficial effects on body weight. Additional beneficial effects on blood pressure and total cholesterol might also be achieved."
They believe that the intervention "should be considered in patients with diabetes who are obese or overweight" and call for further studies "to elucidate the effects of GLP-1R agonists in the treatment of obese patients without diabetes."
While these results highlight the weight-reducing benefits of GLP-1 agonists, they should not alter current practice, says Professor Raj Padwal from the University of Alberta in an accompanying editorial. He argues that "modification of diet and lifestyle remains the cornerstone of the treatment of type 2 diabetes."
He also points out that the safety of GLP-1 agonists is still unknown and says "continued and close surveillance of these new agents using all available data sources is warranted."
Provided by
British Medical Journal
-
Research reveals hormone action that could lead to treatments for type 2 diabetes
Sep 30, 2011 |
not rated yet |
0
-
Improving psoriasis with GLP-1 analogue therapy
Dec 13, 2011 |
not rated yet |
0
-
A new molecule to combat diabetes and obesity
Sep 01, 2009 |
not rated yet |
0
-
Welsh medics to examine how surgery can cure diabetes
May 31, 2007 |
not rated yet |
0
-
Potential mechanisms for future anti-obesity drugs identified
Mar 03, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Mage hand
6 hours ago
-
Sphygmomonometers energy...storage?
8 hours ago
-
How does momentum, inertia and drag affect the motion of an object?
10 hours ago
-
What is Time-Varying Voltage?
12 hours ago
-
Contextual Relationships Between Momentum, Energy, and Force.
13 hours ago
-
Barometric pressure and the math behind it. Very interesting, I think.
15 hours ago
- More from Physics Forums - Classical Physics
More news stories
Young children appear to reject story characters who are obese
(Medical Xpress)—Research by the University of Leeds has shown that very young children appear to reject story book characters who are overweight, but not those who are disabled.
Overweight and Obesity
May 16, 2013 |
3 / 5 (1) |
2
Gene variations may explain weight gain among men, women
(HealthDay)—Weight gain in men and women is predicted by two different genetic variations—so-called polymorphisms, according to a new study from the Netherlands.
Overweight and Obesity
May 15, 2013 |
5 / 5 (1) |
0
|
ECO: Distilled water doesn't up resting energy expenditure
(HealthDay)—Drinking 500 ml of purified water is not associated with increases in resting energy expenditure (REE), according to a study presented at the annual meeting of the European Congress on Obesity, ...
Overweight and Obesity
May 14, 2013 |
2 / 5 (2) |
1
ECO: Industry-funded reviews query sweet drink, obesity tie
(HealthDay)—Reviews that are funded by industry tend to find the evidence weak for a causal link between sugar-sweetened beverages (SSBs) and the increasing prevalence of obesity, while other reviews consider ...
Overweight and Obesity
May 14, 2013 |
not rated yet |
0
The smart phone app that helps weight loss
Researchers at the University of Liverpool have developed a smart phone app that helps users lose weight by carefully recording their food consumption.
Overweight and Obesity
May 13, 2013 |
5 / 5 (1) |
0
AIDS science at 30: 'Cure' now part of lexicon
Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.
For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests
Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...
Melon focus headband turns to Kickstarter for rollout plans
(Medical Xpress)—What if the quality of your work depends more on your focus on the piano keys or canvas or laptop than your musical or painting or computing skills? If target users can be convinced, they ...
Temporal processing in the olfactory system
The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...
Now we know why old scizophrenia medicine works on antibiotics-resistant bacteria
In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...
23 dead in initiation rites in South Africa
(AP)—Twenty-three youths have died in the past nine days at initiation ceremonies that include circumcisions and survival tests, South African police said Friday.
Jan 10, 2012
Rank: not rated yet